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Background: Tegumentary leishmaniasis is an emerging dis-
ease among travelers, and case reports suggest that TL among
travelersmaybeparticularly severe. LeishmaniaRNAvirus-1 (LRV1)
has been implicated in the pathogenesis of severe TL in murine
models, though whether this extends to humans is unknown. We
sought to validate a LRV-1 detection assay.
Methods & Materials: ATCC reference and clinical strains of
Leishmania identiﬁed to species level were screened for LRV1.
Two real time PCR assays for detection of LRV1 were performed
with LRV1 set A and set B primers. Ampliﬁcation of Leishmania
kinetoplastid membrane protein 11 (kmp11) served as a quan-
tiﬁcation and extraction control. ATCC L. (V.) guyanensis strain
MHOM/BR/75/M4147 was used as a positive control.
Results: We screened 5 New World ATCC strains of Leishmania
(L. amazonensis, L. mexicana, L. (V.) braziliensis, L. (V.) panamensis,
and L. (V.) guyanensis) and 12 clinical strains from primary clini-
cal samples including: bone marrow (N=1), whole blood (N=2),
skin scraping (N=2), skin biopsy (N=2), cytology brush (N=4) and
unspeciﬁed (N=1). Causative Leishmania species in clinical speci-
mens were as follows: L. chagasi/infantum (N=3), L. (V.) braziliensis
(N=3), L. tropica (N=2), L. (V.) panamensis (N=1), L. major (N=1),
and L. (V.) guyanensis (N=1). Ampliﬁcation of LRV1 primer sets A
and B along with kmp11 only occurred with the ATCC strain of L.
(V.) guyanensis known to harbour LRV1. Kmp11 alone was ampli-
ﬁed in the remaining ATCC strains, and in 6 of 12 (50%) clinical
strains, thus 80% of ATCC strains and 50% of clinical strains could
be deemed negative for LRV1. Neither LRV1 setA or B primers nor
kmp11 were ampliﬁed in 6 of 12 (50%) clinical strains, leading to
an indeterminant result regarding LRV1 co-infection status.
Conclusion: Detection of LRV1 from clinical strains of Leish-
maniamaybecome relevant to clinicians in the future. Performance
of the LRV1 assay was superior in cultured ATCC strains, which
reﬂects high parasite concentrations in culture compared to pri-
mary clinical specimens. In 50% of clinical isolates, we were able to
assign an LRV1 result, thus, further optimization of assay perfor-
mance in primary clinical specimens is warranted.
http://dx.doi.org/10.1016/j.ijid.2014.03.760
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Background: Tegumentary leishmaniasis is an emerging dis-
ease among travelers. Diagnosis of TL rests on demonstration of
parasites by culture or microscopy, both of which are insensi-
tive and operator dependent. We validated a molecular diagnostic
algorithm for Leishmania detection and species identiﬁcation using
clinical specimens.
Methods & Materials: Microscopy, culture, and Leishmania
genus 18S real time PCR were performed on clinical specimens
sent for Leishmaniadetection betweenMay2012 andOctober 2013.
Specimens positive by 18S PCR were subjected to ITS1 end-point
PCR followed by restriction fragment length polymorphism (RFLP),
which identiﬁes L. donovani, L. chagasi/infantum, L. major, L. tropica,
L. amazonensis, and L. mexicana. For the Viannia sub-genus, ampli-
ﬁcation of the ITS1 region differentiates L. (V.) braziliensis from the
other species within the complex. Species identiﬁcation was con-
ﬁrmed by Sanger sequencing of the ITS2 region or by a combination
of Mpi (mannose phosphate isomerase), Cpb (cysteine proteinase
b), andHsp70 (heat shock protein-70) PCR-RFLP/Sanger sequencing
for L. Viannia complex.
Results: Forty-ﬁve specimens from 36 individuals were tested
for Leishmania during the study period, and of these, 20 spec-
imens from 14 individuals were positive. Primary specimens
were as follows: bone marrow (N=5), organ (N=2), whole blood
(N=3), skin scraping (N=5), skin biopsy (N=10), skin aspirate
(N=9), ﬁlter paper (N=3), cytology brush (N=5) and unspeciﬁed
(N=3). Compared to 18S PCR (gold standard), culture had a sen-
sitivity of 15% and speciﬁcity of 100%, while microscopy had a
sensitivity of 27% and speciﬁcity of 100%. Among the 14 individ-
uals with conﬁrmed Leishmania infection, causative species were
as follows: L. tropica (N=3), L. (V.) panamensis (N=3), L. cha-
gasi/infantum (N=2), L. major (N=2), L. (V.) braziliensis (N=2), and
L. (V.) guyanensis (N=1). Turnaround time of 18S and ITS1 PCR is
2 days, while 18S PCR followed by PCR-RFLP or ITS2 sequencing is
4 days.
Conclusion: Using a combination of end-point and real time
PCR, along with RFLP and sequencing, we have demonstrated reli-
able detection and species identiﬁcation of Leishmania froma range
of primary clinical specimens. The utility of culture andmicroscopy
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is limited by poor sensitivity, technical expertise, and in the case of
culture, slow turnaround time.
http://dx.doi.org/10.1016/j.ijid.2014.03.761
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Background: Toxocariasis is associated with three syndromes
in human beings which are visceral larva migrans, ocular larva
migrans and covert toxocariasis. Although neurotoxocariasis is
deﬁned as the fourth syndrome of toxocariasis, it is usually consid-
ered as a neurological disease which is usually concomitant with
visceral larva migrans. I˙n this abstract we report a case of brain
abcess caused by toxocariasis.
Methods & Materials: A 56 years-old female patient admitted
at our hospital with headache, pain referring to right side of her
face and teeth, numbness of forth and ﬁfth ﬁnger of her right hand.
Cranial diffusion weighted, dynamic magnetic resonance imaging
(MRI) revealed a few non- spesiﬁc intensities at supratentorial
white matter, and an approximately 13x12mm lesion without
contrast enhancement which had a signiﬁcant edema around the
whitematter in the left frontal cortex. Histologic examination after
stereotactic biopsy of the lesion revealed diffuse histiocyte inﬁltra-
tion in histological examination.
Results: A spesiﬁc agent could not be detected in histochemical
examination.Western-blot test toxocariasis in serumand CSFwere
positive. She was transferred to the infectious diseases and clinical
microbiology clinic.Albendazole 400mg q12h was started. A total
of onemonthduration for albendazole treatmentwasplanned after
regression of the cranial MRI ﬁndings on the 14th day of therapy.
The patient is recalled for cranial MRI control three months later.
However, we found out that she continued albendazole for three
months. Compared to the previous MRI, there were two stabilized
T2A hyperintense lesions in left cranial hemisphere and minimally
regressed lesions at the level of left frontal centrum semi-ovale.
There was no relapse after six month follow up. The
Conclusion: The presented case suggests that although rarely
neurotoxocariasismaybe encountered in the etiology of encephali-
tis/brain abcess. The patient was successfully treated with
albendazole. To our knowledge this is the ﬁrst reported case of
neurotoxocariasis n Turkey.
http://dx.doi.org/10.1016/j.ijid.2014.03.762
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Background: The WHO recommends that praziquantel is
administered to all children above four years of age living in schis-
tosoma endemic areas. The frequency of mass drug administration
depends on the community’s prevalence level. Urine egg count
remains the gold standard method for measuring prevalence lev-
els and it is usually done immediately prior to mass treatment.
This study aims to explore the inﬂuence of seasons on urine egg
excretion.
Methods & Materials: In a schistosomiasis endemic area in
southernKwaZulu-Natal, SouthAfrica,where the climate is charac-
terizedbyhotandhumidsummers (high-transmission-season)and
cool, dry winters (low-transmission-season) two cross-sectional
studieswere performed in randomly selected schools: (1) February
to November (2009, 2010 or 2011) urines were collected from
females aged 10-12 and 16-23 years (n =1988), (2) May to
September 2011 urines were collected from randomly selected
school girls aged 4-23 years (n =2371). No mass-treatment had
been performed prior to the surveys. Urines were examined for
S. haematobium eggs by microscopy.
Results: In the4359urine samples from females aged4-23years
(mean13.35, SD4.1) 24.6%were S. haematobiumpositive. The num-
ber of female pupils with eggs in urine ﬂuctuated in parallel with
the transmission seasons. The prevalence was signiﬁcantly higher
immediately after the high-transmission season, summer, 37.8%
positive, than in the low-transmission-season, winter, 14.5% posi-
tive (OR 0.68, 95%CI 0.62-0.76, p <0.01). There was no inﬂuence of
age on the association. Likewise, the intensity of infection in the
positive girls was signiﬁcantly lower in winter (Mann-Whitney U
Test, p =0.049).
Conclusion: This study shows that the number of subjects
excreting S. haematobium ova in urine varies by season. The S.
haematobium prevalence was highest immediately after the high-
transmission season. In our study area urines are best collected
shortly after the hottest season in order to make decisions about
eligibility for mass-treatment, whereas treatment is known to be
most efﬁcient when given in the cool season. Further studies are
needed to conﬁrm whether egg excretion has to do with factors
such as temperature, high-transmission, rainfall, parasite fecun-
dity, or intensiﬁed water activity.
http://dx.doi.org/10.1016/j.ijid.2014.03.763
